Immunologic Research

Papers
(The H4-Index of Immunologic Research is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
The effect of mutatio-type on proteo-phenotype and clinico-phenotype in selected primary immunodeficiencies59
B cell repertoire in patients with a novel BTK mutation: expanding the spectrum of atypical X-linked agammaglobulinemia58
Somatic hypermutation defects in two adult hyper immunoglobulin M patients58
MiR-29a-3p negatively regulates circulating Tfh memory cells in patients with Graves’ disease by targeting ICOS57
Rapid generation of an RBL cellular model to study proteins that cause allergenic reactions in vitro52
Quantitative evaluation of citrullinated fibrinogen for detection of neutrophil extracellular traps50
Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis39
Belimumab 10 years later: how drug positioning has changed38
A case of atypical infantile de novo antiphospholipid syndrome presenting with neonatal ischemic stroke without any triggering risk factors as a “second hit” and review of the literature37
Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis34
Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey32
Macrophage subsets and their role: co-relation with colony-stimulating factor-1 receptor and clinical relevance32
Hypoxia modulates human mast cell adhesion to hyaluronic acid27
[Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer25
A ubiquitin–proteasome system-related signature to predict prognosis, immune infiltration, and therapy efficacy for breast cancer24
ANCA detection with solid phase chemiluminescence assay: diagnostic and severity association in vasculitis24
Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors24
Clinical relevance and frequency of cytoplasmic patterns observed in ANA-Hep-2: experience of Cairo University Hospitals22
Immune tumoral microenvironment in gliomas: focus on CD3+ T cells, Vδ1+ T cells, and microglia/macrophages21
Activation of autophagy reverses gemcitabine-induced immune inhibition of RAW264.7 macrophages by promoting TNF-α, IL-6 and MHC-II expression21
Lipocalin 2—not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials21
0.15535998344421